115 related articles for article (PubMed ID: 30112728)
1. A Critical Evaluation of Safety Signal Analysis Using Algorithmic Standardised MedDRA Queries.
Tieu C; Breder CD
Drug Saf; 2018 Dec; 41(12):1375-1385. PubMed ID: 30112728
[TBL] [Abstract][Full Text] [Related]
2. Standardised MedDRA queries: their role in signal detection.
Mozzicato P
Drug Saf; 2007; 30(7):617-9. PubMed ID: 17604415
[TBL] [Abstract][Full Text] [Related]
3. A Method for Retrieval of Adverse Event Terms in Clinical Trial Databases Using Standardised MedDRA Queries.
Breder CD
Pharmaceut Med; 2016 Apr; 30(2):103-108. PubMed ID: 27274655
[TBL] [Abstract][Full Text] [Related]
4. Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications.
Chang LC; Mahmood R; Qureshi S; Breder CD
PLoS One; 2017; 12(6):e0178104. PubMed ID: 28570569
[TBL] [Abstract][Full Text] [Related]
5. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
Dupuch M; Grabar N
J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
[TBL] [Abstract][Full Text] [Related]
6. Performance of the standardised MedDRA® queries for case retrieval in the French spontaneous reporting database.
Géniaux H; Assaf D; Miremont-Salamé G; Raspaud B; Gouverneur A; Robinson P; Pariente A; Salvo F
Drug Saf; 2014 Jul; 37(7):537-42. PubMed ID: 24942754
[TBL] [Abstract][Full Text] [Related]
7. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Methodology to Systematically Identify Drug Hypersensitivity and Anaphylactic Reactions in Clinical Trial Databases.
Xavier H; Hara I; Ottesen LH; Verheijen RB; Ghiorghiu D; Morgan C
Pharmaceut Med; 2020 Oct; 34(5):335-345. PubMed ID: 32975782
[TBL] [Abstract][Full Text] [Related]
9. Grouping pharmacovigilance terms with semantic distance.
Dupuch M; Lerch M; Jamet A; Jaulent MC; Fescharek R; Grabar N
Stud Health Technol Inform; 2011; 169():794-8. PubMed ID: 21893856
[TBL] [Abstract][Full Text] [Related]
10. Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).
Brown EG
Drug Saf; 2003; 26(3):145-58. PubMed ID: 12580645
[TBL] [Abstract][Full Text] [Related]
11. A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases.
Arnaud M; Salvo F; Ahmed I; Robinson P; Moore N; Bégaud B; Tubert-Bitter P; Pariente A
Drug Saf; 2016 Mar; 39(3):251-60. PubMed ID: 26715499
[TBL] [Abstract][Full Text] [Related]
12. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
[TBL] [Abstract][Full Text] [Related]
13. Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.
Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Schönfeldt-Lecuona C
J Clin Pharmacol; 2016 Jun; 56(6):769-78. PubMed ID: 26470856
[TBL] [Abstract][Full Text] [Related]
14. Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
Huang L; Zalkikar J; Tiwari RC
J Biopharm Stat; 2013; 23(1):178-200. PubMed ID: 23331230
[TBL] [Abstract][Full Text] [Related]
15. Application of information retrieval approaches to case classification in the vaccine adverse event reporting system.
Botsis T; Woo EJ; Ball R
Drug Saf; 2013 Jul; 36(7):573-82. PubMed ID: 23703591
[TBL] [Abstract][Full Text] [Related]
16. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
17. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.
Aagaard L; Hallgreen CE; Hansen EH
Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924
[TBL] [Abstract][Full Text] [Related]
18. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
[TBL] [Abstract][Full Text] [Related]
19. Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database.
Hauben M; Hung EY; Hanretta KC; Bangalore S; Snow V
Drug Saf; 2015 Nov; 38(11):1127-39. PubMed ID: 26242615
[TBL] [Abstract][Full Text] [Related]
20. Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project.
Avillach P; Coloma PM; Gini R; Schuemie M; Mougin F; Dufour JC; Mazzaglia G; Giaquinto C; Fornari C; Herings R; Molokhia M; Pedersen L; Fourrier-Réglat A; Fieschi M; Sturkenboom M; van der Lei J; Pariente A; Trifirò G;
J Am Med Inform Assoc; 2013 Jan; 20(1):184-92. PubMed ID: 22955495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
